Medicxi Ventures Management (Jersey) Ltd - CHECKMATE PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Medicxi Ventures Management (Jersey) Ltd ownership history of CHECKMATE PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2022$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2022$4,790,000
+11.1%
1,501,7160.0%1.30%
+20.3%
Q4 2021$4,310,000
-27.7%
1,501,7160.0%1.08%
-16.8%
Q3 2021$5,962,000
-33.4%
1,501,7160.0%1.30%
-19.1%
Q2 2021$8,950,000
-50.9%
1,501,7160.0%1.60%
-84.9%
Q1 2021$18,231,000
-16.8%
1,501,7160.0%10.62%
-16.6%
Q4 2020$21,910,000
+26.8%
1,501,7160.0%12.73%
+54.3%
Q3 2020$17,284,0001,501,7168.25%
Other shareholders
CHECKMATE PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 1,501,716$21,910,00012.73%
venBio Partners LLC 3,673,374$53,595,0004.73%
Sofinnova Investments, Inc. 3,606,707$52,622,0003.13%
Omega Fund Management, LLC 1,335,050$19,478,0002.92%
CLOUGH CAPITAL PARTNERS L P 1,332,397$19,353,0001.38%
Novo Holdings A/S 2,170,100$31,662,0001.36%
SECTORAL ASSET MANAGEMENT INC 548,802$8,007,0000.56%
Ensign Peak Advisors, Inc 119,915$1,750,0000.00%
DEUTSCHE BANK AG\ 203,534$2,970,0000.00%
Tower Research Capital LLC (TRC) 1,326$19,0000.00%
View complete list of CHECKMATE PHARMACEUTICALS IN shareholders